Complementary effect of Roe's congenital heart disease treatment compared to Wade's

Published Date: 16 Feb 2023

As more states repeal or restrict abortion laws, the number of patients, the number of workers needed, and the cost of heart disease will increase. How should hospitals and policy makers prepare?

Read Full News

Latest News

Genetic Risk Tied to Postpartum BP Risk, BMI Matters More

First-time mothers with high genetic risk for systolic blood pressure have a higher likelihood of postpartum hypertension, but BMI and hypertensive pregnancy disorders are stronger risk factors.

Apixaban May Cut Stroke Risk but Raise Bleeding in Dialysis

Observational data suggest apixaban leads to fewer thromboembolic events but higher bleeding risk, highlighting the need for individualized decision-making in dialysis patients.

AI Model Can Help Cut Hospitalizations in Dialysis Patients

AI-driven interventions reduce the odds of hospitalization within 7 days by 8% in patients with end-stage kidney disease receiving hemodialysis, according to a recent study.

The Case for Muscle Power Over Strength

The ability to move a weight with force may be a better predictor of mortality risk than how much weight you can move overall. A beneficial tweak for exercise Rx?

Wall Thickness Heterogeneity Improves Cardiomyopathy Detection

Heterogeneity in the thickness of the heart wall, represented by wall thickness standard deviation, can improve the early detection of hypertrophic cardiomyopathy and mutation carriers, a study shows.

PVR Reduced in Adults With HFpEF, Pulmonary Hypertension

In a phase 2 trial, treatment with sotatercept shows reduced pulmonary vascular resistance and heart outcomes in patients with combined postcapillary and precapillary pulmonary hypertension and HFpEF.

Todays Updates

Is the Viral Plastic Diet Linked to Eating Disorder Risk?

A viral plastic diet trend raises concerns for choking, metabolic disruption, and increased risk for eating disorders among youth.

Exercise Intensity Over Volume Linked to Lower Disease Risks

Higher intensity of physical activity, regardless of total volume, is linked to significantly lower risks for many cardiovascular and other chronic diseases and death.

Todays Updates

Is the Viral Plastic Diet Linked to Eating Disorder Risk?

A viral plastic diet trend raises concerns for choking, metabolic disruption, and increased risk for eating disorders among youth.

Exercise Intensity Over Volume Linked to Lower Disease Risks

Higher intensity of physical activity, regardless of total volume, is linked to significantly lower risks for many cardiovascular and other chronic diseases and death.

Latest News

First-time mothers with high genetic risk for systolic blood pressure have a higher likelihood of postpartum hypertension, but BMI and hypertensive pregnancy disorders are stronger risk factors.

Observational data suggest apixaban leads to fewer thromboembolic events but higher bleeding risk, highlighting the need for individualized decision-making in dialysis patients.

AI-driven interventions reduce the odds of hospitalization within 7 days by 8% in patients with end-stage kidney disease receiving hemodialysis, according to a recent study.

The ability to move a weight with force may be a better predictor of mortality risk than how much weight you can move overall. A beneficial tweak for exercise Rx?

Heterogeneity in the thickness of the heart wall, represented by wall thickness standard deviation, can improve the early detection of hypertrophic cardiomyopathy and mutation carriers, a study shows.

In a phase 2 trial, treatment with sotatercept shows reduced pulmonary vascular resistance and heart outcomes in patients with combined postcapillary and precapillary pulmonary hypertension and HFpEF.

News All Time

Impella Comes Up Short in High-Risk PCI: CHIP-BCIS3

High-risk patients with left ventricular dysfunction fare as well, or better, without the support of a microaxial flow pump during complex PCI procedures than those provided with a microaxial flow pump.

Two Oral GLP-1s Increase Options for Patient Care

Eli Lilly and Novo Nordisk are in heated competition over orforglipron versus oral semaglutide, respectively, while injectables remain the more potent obesity treatment options.

Shingles Vaccine Lowers Cardiovascular Risk

Patients with atherosclerotic cardiovascular disease who had received herpes zoster vaccination saw reductions in major adverse cardiac events.

Younger Age Offers No Protection From HFrEF Deaths

Patients with heart failure with reduced ejection fraction, especially those aged 40-49 years, have higher 5-year mortality than peers from the general population.

Active Breath Control Cuts Radiation Dose to Heart

Active breath control significantly reduced radiation dose to the heart and a major artery during treatment for left-sided breast cancer, new data show.

Hormonal Contraception and IIH Risk: New Data

A systematic review and meta-analysis sheds light on the debated association between hormonal contraception and risk for idiopathic intracranial hypertension.

Concerns Continue Over Proposed New Obesity Definitions

The Endocrine Society has concerns of possible delays in care and other problematic areas of The Lancet Commission’s proposed new obesity framework; a Commission author cites ‘conceptual confusions.’

SGLT2i Show Cardiorenal, Liver Benefits in Cirrhosis

In patients with type 2 diabetes and cirrhosis, SGLT2 inhibitors show increased efficacy over DPP-4 inhibitors in kidney, cardiac, and liver outcomes.

Stroke Support System Linked to Fewer Vascular Events

An AI-assisted clinical decision-support system is associated with reduced incidence of vascular events in patients with acute ischemic stroke, a new study shows.

12 Common Hypertension Pitfalls and How to Fix Them

A review identifies 12 common hypertension errors, highlighting missed diagnostic steps and treatment gaps that may affect long-term cardiovascular outcomes.

Transcatheter ViV Safe for Failed Bioprostheses

A valve-in-valve procedure for dysfunctional bioprosthetic mitral valves had lower 1-year risk for death and stroke than redo surgery, according to a clinical trial.

All-RISE, FAST III: Novel FFR Noninferior to Standard

Two trials showed novel angiography-based physiology assessments were comparable to pressure wire-based approaches for guiding percutaneous coronary intervention.

Sirolimus-Coated Balloon Reduces PAD Amputation Risk

Angioplasty with sirolimus-coated balloons, as compared with uncoated balloons, reduced limb amputation and other adverse events in the SirPAD trial.

Incidental Liver Lesions Common in Patients With CHD on cMRI

Nearly 10% of patients with congenital heart disease have incidental liver lesions detected during cardiac MRI, the majority of which being previously unknown to clinicians.

Wireless Monitoring Saves Time, May Save Lives

Continuous wireless monitoring reduced in-hospital complications and mortality in an Italian pilot trial and significantly eased nursing workload.

Guideline Offers Holistic View of Brain-Heart Comorbidities

The aim of the new guideline is to expand on current cardiovascular guidelines to include evidence from the neurologic and mental health literature.

Recommended News For You

Another KRAS Inhibitor Scores an Early Win in Advanced Non-Small Cell Lung Cancer

Worse Outcomes After Esophagectomy at Private Equity-Owned Hospitals

'Cell-in-cell' mechanism explains how blood cancer uses bone marrow to evade treatment

Axatilimab Demonstrates Effectiveness in Refractory/Recurrent GVHD.

Should the UK introduce targeted prostate cancer screening? The case for and against

Despite reports of hundreds of cancer cases, carcinogens have been discovered at nuclear missile sites in Montana.

ASTRO Guideline Addresses Specifics of HPV-Associated Oropharyngeal Cancer

Recommended Articles For You

Anion Gap: The Simple Calculation That Reveals Much About Your Health  

Oncolytic Vaccinia Virus Immunotherapy: A New Frontier in GI Cancer Treatment 

Unlocking the Immune Arsenal: A Revolution in Cancer Treatment 

Bispecific Antibodies in DLBCL & Myeloma: Clinical Insights for Physicians 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

TRK Inhibitor Active in Treatment-Refractory Glioblastoma

2.

Hydroxyurea Shows Some Benefits in Milder Sickle Cell Disease

3.

In high-risk muscle invasive urothelial cancer, adjuvant pembrolizumab improves disease-free survival.

4.

Research finds COVID-19 mRNA vaccine sparks immune response to fight cancer

5.

VP Nominee Medical Records Breached; Queen Elizabeth's Cancer; Galaxy Gas Whippets

1.

The New Frontier of Cancer Survivorship: Navigating the Long-Term Effects of Immunotherapy and Targeted Therapies

2.

Direct Oral Anticoagulants (DOACs) in Atrial Fibrillation: A Comprehensive Review

3.

Unveiling the Chadwick Sign: A Revolutionary New Tool for Detecting Early Signs of Cancer

4.

The Capmist DM: A Revolutionary Way to Combat Dry Mouth

5.

Hypercoagulable State: Factors that Contribute to Blood Clots 

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part IV

2.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part IV

3.

Efficient Management of First line ALK-rearranged NSCLC - Part VII

4.

First-Line Maintenance Therapy for Metastatic Urothelial Carcinoma: Bridging Clinical Practice and Trials

5.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part I

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot